111 related articles for article (PubMed ID: 25429778)
21. New neurotensin analogue radiolabeled by 99m-technetium as a potential agent for tumor identification.
Emrarian I; Sadeghzadeh N; Abedi SM; Abediankenari S
Chem Biol Drug Des; 2018 Jan; 91(1):304-313. PubMed ID: 28816013
[TBL] [Abstract][Full Text] [Related]
22. Tocilizumab Labeling with 99mTechnetium via HYNIC as a Molecular Diagnostic Agent for Multiple Myeloma.
Camacho X; Machado CL; García MF; Fernández M; Oddone N; Benech J; Gambini JP; Cerecetto H; Chammas R; Cabral P; Riva E
Anticancer Agents Med Chem; 2017; 17(9):1267-1277. PubMed ID: 28270081
[TBL] [Abstract][Full Text] [Related]
23.
Ahmadpour S; Noaparast Z; Abedi SM; Hosseinimehr SJ
Anticancer Agents Med Chem; 2018; 18(9):1295-1302. PubMed ID: 29521248
[TBL] [Abstract][Full Text] [Related]
24. Microwave-assisted synthesis of organometallic complexes of ⁹⁹mTc(CO)₃ and Re(CO)₃: its application to radiopharmaceuticals.
Kimura H; Mori D; Harada N; Ono M; Ohmomo Y; Kajimoto T; Kawashima H; Saji H
Chem Pharm Bull (Tokyo); 2012; 60(1):79-85. PubMed ID: 22223378
[TBL] [Abstract][Full Text] [Related]
25. Tricine co-ligand improved the efficacy of
Shaghaghi Z; Abedi SM; Hosseinimehr SJ
Biomed Pharmacother; 2018 Aug; 104():325-331. PubMed ID: 29775901
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and characterization of rhenium and technetium-99m labeled insulin.
Sundararajan C; Besanger TR; Labiris R; Guenther KJ; Strack T; Garafalo R; Kawabata TT; Finco-Kent D; Zubieta J; Babich JW; Valliant JF
J Med Chem; 2010 Mar; 53(6):2612-21. PubMed ID: 20235598
[TBL] [Abstract][Full Text] [Related]
27. Control of radioactivity pharmacokinetics of 99mTc-HYNIC-labeled polypeptides derivatized with ternary ligand complexes.
Ono M; Arano Y; Mukai T; Saga T; Fujioka Y; Ogawa K; Kawashima H; Konishi J; Saji H
Bioconjug Chem; 2002; 13(3):491-501. PubMed ID: 12009938
[TBL] [Abstract][Full Text] [Related]
28. A technetium intermediate specifically promotes deprotection of trifluoroacetyl HYNIC during radiolabelling under mild conditions.
Surfraz MB; Biagini SC; Blower PJ
Dalton Trans; 2008 Jun; (22):2920-2. PubMed ID: 18493625
[TBL] [Abstract][Full Text] [Related]
29. Cyclic minigastrin analogues for gastrin receptor scintigraphy with technetium-99m: preclinical evaluation.
von Guggenberg E; Sallegger W; Helbok A; Ocak M; King R; Mather SJ; Decristoforo C
J Med Chem; 2009 Aug; 52(15):4786-93. PubMed ID: 19591486
[TBL] [Abstract][Full Text] [Related]
30. Development of a novel 99mTc-chelate-conjugated bisphosphonate with high affinity for bone as a bone scintigraphic agent.
Ogawa K; Mukai T; Inoue Y; Ono M; Saji H
J Nucl Med; 2006 Dec; 47(12):2042-7. PubMed ID: 17138748
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and evaluation of a 99mTechnetium labeled chitin-binding protein as potential specific radioligand for the detection of fungal infections in mice.
Siaens R; Eijsink VG; Vaaje-Kolstad G; Vandenbulcke K; Cornelissen B; Cuvelier C; Dierckx R; Slegers G
Q J Nucl Med Mol Imaging; 2006 Sep; 50(3):155-66. PubMed ID: 16868531
[TBL] [Abstract][Full Text] [Related]
32. 99mTc-Labeling of a hydrazinonicotinamide-conjugated LTB(4) receptor antagonist useful for imaging infection and inflammation.
Liu S; Harris AR; Williams NE; Edwards DS
Bioconjug Chem; 2002; 13(4):881-6. PubMed ID: 12121145
[TBL] [Abstract][Full Text] [Related]
33. Radiolabelling morpholinos with 188Re tricarbonyl provides improved in vitro and in vivo stability to re-oxidation.
He J; Liu C; Vanderheyden JL; Liu G; Dou S; Rusckowski M; Hnatowich DJ
Nucl Med Commun; 2004 Jul; 25(7):731-6. PubMed ID: 15208502
[TBL] [Abstract][Full Text] [Related]
34. 99mTc-labeled 1-thio-beta-D-glucose as a new tumor-seeking agent: synthesis and tumor cell uptake assay.
Jun Oh S; Ryu JS; Yoon EJ; Bae MS; Choi SJ; Park KB; Moon DH
Appl Radiat Isot; 2006 Feb; 64(2):207-15. PubMed ID: 16168660
[TBL] [Abstract][Full Text] [Related]
35. On the synthesis, isolation, and radiochemical studies for the preparation of in-house kits for 99mTc-meso- and d,l-HMPAO: a few additional observations.
Banerjee S; Samuel G; Kothari K; Sarma HD; Pillai MR
Nucl Med Biol; 1999 Apr; 26(3):327-38. PubMed ID: 10363805
[No Abstract] [Full Text] [Related]
36. In vivo and in vitro characterizations of three 99mTc-labeled monoclonal antibody G250 preparations.
Steffens MG; Oosterwijk E; Kranenborg MH; Manders JM; Debruyne FM; Corstens FH; Boerman OC
J Nucl Med; 1999 May; 40(5):829-36. PubMed ID: 10319758
[TBL] [Abstract][Full Text] [Related]
37. Introduction of an 8-aminooctanoic acid linker enhances uptake of 99mTc-labeled lactam bridge-cyclized α-MSH peptide in melanoma.
Guo H; Miao Y
J Nucl Med; 2014 Dec; 55(12):2057-63. PubMed ID: 25453052
[TBL] [Abstract][Full Text] [Related]
38. Technetium-99m-Labeled N-(2-hydroxypropyl) methacrylamide copolymers: synthesis, characterization, and in vivo biodistribution.
Mitra A; Nan A; Ghandehari H; McNeill E; Mulholland J; Line BR
Pharm Res; 2004 Jul; 21(7):1153-9. PubMed ID: 15290854
[TBL] [Abstract][Full Text] [Related]
39. Optimization of the preparation of 99mTc-labeled Hynic-derivatized Annexin V for human use.
Verbeke K; Kieffer D; Vanderheyden JL; Reutelingsperger C; Steinmetz N; Green A; Verbruggen A
Nucl Med Biol; 2003 Oct; 30(7):771-8. PubMed ID: 14499336
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, characterization, and labeling with 99mTc/188Re of peptide conjugates containing a dithia-bisphosphine chelating agent.
Gali H; Hoffman TJ; Sieckman GL; Owen NK; Katti KV; Volkert WA
Bioconjug Chem; 2001; 12(3):354-63. PubMed ID: 11353532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
